Pharmaceutical Technology20m
Intellia’s gene editing therapy shows early potential in rare heart condition
Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in ...
Stem Cell Therapy Market Expected To Reach 31.33 Billion, Growing At 11.20% CAGR By 2032 | Introspective Market Research
( MENAFN - GlobeNewsWire - Nasdaq) Stem Cell Therapy market Size Was Valued at USD 12.05 Billion in 2023, and is Projected to Reach USD 31.33 Billion by 2032, Growing at a CAGR of 11.20% From ...